GENEVA, Sept. 8 -- UNIVERSALVAX BIOTECHNOLOGIES (TAIZHOU) CO., LTD. (A406, Vaccine Engineering Center, No. 28 Xinglin Road, Pharmaceutical High-Tech Industrial Development ZoneTaizhou, Jiangsu 225300), 普大生物科技(泰州)有限公司 (中国江苏省泰州市医药高新技术产业开发区杏林路28号疫苗工程中心A406) filed a patent application (PCT/CN2024/129834) for "RSV NANOPARTICLE VACCINE AND PREPARATION METHOD THEREFOR" on Nov 05, 2024. With publication no. WO/2025/179940, the details related to the pat...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.